Small Doses: News for Pharmacists This week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you. Four areas of unnecessary senior healthcare October 04, 2016 By Aine Cryts Two reports highlight areas of elderly care that healthcare systems and health plans should avoid. New Products: Neuromodulation system for OAB targets tibial nerve July 15, 2016 By Ben Schwartz Other products discussed in this roundup include a plasma vaporization device, a laser fiber safety device, and more. New Products: MRI System improves lesion conspicuity, biopsy device receives FDA clearance and an App that tracks stent implants Check out the latest products. From an MRI System that improves lesion conspicuity, a biopsy device receives FDA clearance and an App that tracks stent implants. PCa studies: Optimized screening, treatment selection essential February 11, 2016 By Annamarie Iannetta Four PCa studies presented at the 2015 AUA annual meeting in New Orleans shed some light, with researchers emphasizing the need to optimize screening and to improve treatment selection in older men. New Products: Single-use ureteroscope, new FDA Approvals for RCC treatment, and an App that helps IC, chronic prostatitis patients January 26, 2016 By Annamarie Iannetta Check out the latest new products. From Single-use ureteroscope addresses shortcomings of reusable scopes, to an App that helps IC, chronic prostatitis patients choose the right foods and much more. Abiraterone/low-dose prednisone show efficacy in PCa Phase II study results show that daily treatment with abiraterone acetate (ZYTIGA), 1,000 mg, plus prednisone, 5 mg was very effective in lowering PSA levels in men with non-metastatic castrate-resistant prostate cancer (CRPC) at high risk for metastasis. Learn more Advanced prostate cancer: Why men aren’t speaking up October 01, 2015 Hear and get results from Neal Shore, MD, as he discusses with Crystal Murcia, PhD the surveys findings, explains why men aren’t speaking up about their prostate cancer symptoms, and urologists' role in assessing how patients are feeling. New Products: FDA approves oral agent for HSDD, app helps men with erectile dysfunction and more September 01, 2015 By Annamarie Iannetta In this round-up of new urology products and services, learn about the FDA approving an oral agent for HSDD, an app that helps men with erectile dysfunction, and more. New Products: Compounded formulations for IC, ED and more Other products featured include: Radiosurgery collimator allows treatment of broad rang of tumors and Phi prostate cancer test and more.